A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
Clinical trial NCT06965413 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06965413
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-05
- Primary completion
- 2026-08-22
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.